Star Lake Bioscience Co., Inc.zhaoqing Guangdong
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | The predecessor of Guangdong Zhaoqing Xinghu Biotechnology Co., Ltd. was an agricultural microbial pharmaceutical factory established in 1964. In 1981, it was converted into monosodium glutamate. In 1992, it was transformed into a joint-stock company based on the original state-owned enterprise Zhaoqing monosodium glutamate factory. It is one of the first eight pilot joint-stock reform enterprises in Guangdong Province. In August 1994, the company's stock was listed on the Shanghai Stock Exchange, abbreviated as "Xinghu Technology" with stock code 600866. In April 2009, Guangdong Guangxin Holding Group acquired the state-owned control of Xinghu Technology held by the State owned Assets Supervision and Administration Commission of Zhaoqing City. The company has established a national level enterprise technology center and a postdoctoral research workstation. It is a key high-tech enterprise of the National Torch Program, an excellent high-tech enterprise of the National Torch Program, a high-tech enterprise in Guangdong Province, a technological innovation advantage enterprise in Guangdong Province, and an innovative enterprise in Guangdong Province. Won the title of National Energy Saving exemplary organization during the "Eleventh Five Year Plan" period, and the title of "National Food Industry Excellent Leading Food Enterprise in 2012-2013". The "Xinghu Brand" and "Yuebao Brand" trademarks have been awarded as excellent independent brands and famous trademarks in Guangdong Province. The company's main products include: Xinghu brand food series - high-end products such as flavored nucleotide disodium (I+G), inosine disodium (IMP), guanosine disodium (GMP), and fructose F55, F42. Yuebao brand pharmaceutical series - inosine, ribavirin, proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, arginine, ribose, etc; Xinghu brand feed additive series - valine, threonine, lysine, etc. Further clarify the development direction, leverage core technological advantages, vigorously cultivate and develop the biopharmaceutical and food health industries, follow the industrial development path of low dependence on energy, resources, and raw materials, high technological content, high added value, large market capacity, environmental protection, energy conservation, and clean production, extend the industrial chain, create core industries, and accelerate transformation and upgrading. Fully utilize the platform of listed companies, integrate resources, actively innovate business models through capital operation, accelerate the development of new growth points, and promote high-quality and leapfrog development of the company. |
| Headquarter | Zhaoqing |
| Establish Date | 4/18/1992 |
| Listed Code | 600866.SH |
| Listed Date | 8/18/1994 |
| Chairman | Liu Libin. |
| CEO | Ying Jun. |
| Website | www.starlake.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
